April 30, 2025 08:45 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
PM Modi to skip Russia's Victory Day parade on May 9 in backdrop of Pahalgam attack | PM Modi holds top cabinet meetings amid India's wait for Pahalgam terror attack revenge | Fire in Kolkata hotel kills 14, police constitute SIT; local administration faces heat over 'negligence' | India will attack us in next 24-36 hours, claims Pakistan minister with warning of 'catastrophic consequences' | 3 killed, several injured in shooting incident in Sweden's Uppsala | BREAKING: PM Modi gives 'full freedom' to forces to avenge Pahalgam terror attack | Canada: Indian student Vanshika, who went missing for past few days, found dead | J&K govt closes 48 tourist locations as intel warns of more terror attacks after Pahalgam incident | Mark Carney leads Liberal Party to victory in Canada, Khalistan sympathiser Jagmeet Singh bites dust | India calls Pakistan 'a rogue state fuelling global terrorism' at UN amid rising border tension after Pahalgam attack
Sinopharm
Image Credit: wikipedia.org

China's Sinopharm Covid-19 vaccine gets WHO's nod for emergency use

| @indiablooms | May 08, 2021, at 04:50 am

Geneva/IBNS: The World Health Organisation (WHO) on Friday gave emergency use approval for a coronavirus vaccine made by China's state-owned drug manufacturer Sinopharm, said a Reuters report.

The vaccine is one of the two shots made by China and has been exported to several countries and given to millions of people in China, according to the report.

It is also the first vaccine made by a non-western country to get the UN health body's approval and also the first Chinese vaccine to get its nod for any infectious disease, the report said.

This draws significance as WHO's approval is a benchmark of safety and efficacy of a product for countries. It also means that the Chinese vaccine can now be included in COVAX, the programme to make available coronavirus vaccine to poor countries across the globe.

Johnson & Johnson, AsyraZeneca, Pfizer-BioNTech and Moderna have so far received approval for emergency use from WHO.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.
Close menu